Abrogating GPT2 in triple negative breast cancer inhibits tumor growth and promotes autophagy. Mitra D, Vega-Rubin-de-Celis S, Royla N, Bernhardt S, et al. Int J Cancer 2020 Dec 24. doi: 10.1002/ijc.33456.

Read + Share

Amedeo Smart

Independent Medical Education

Mitra D, Vega-Rubin-de-Celis S, Royla N, Bernhardt S, et al. Abrogating GPT2 in triple negative breast cancer inhibits tumor growth and promotes autophagy. Int J Cancer 2020 Dec 24. doi: 10.1002/ijc.33456.
PMID: 33368291